A detailed history of Prelude Capital Management, LLC transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Prelude Capital Management, LLC holds 27,504 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,504
Previous 27,504 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
27,504 New
27,504 $0
Q4 2023

Feb 14, 2024

BUY
N/A
22,745 New
22,745 $0
Q1 2023

May 15, 2023

BUY
N/A
21,295 New
21,295 $0
Q4 2019

Feb 14, 2020

SELL
$9.09 - $11.89 $14,907 - $19,499
-1,640 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$9.66 - $12.36 $9,186 - $11,754
951 Added 138.03%
1,640 $18,000
Q2 2019

Aug 14, 2019

BUY
$9.32 - $12.98 $6,421 - $8,943
689 New
689 $6,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.